Drug intelligence / Profile preview

Prothrombin

Development stage
Unknown
Lead developer
CSL Behring
Modality
Recombinant Proteins and Enzymes
Administration
Intravenous
01

Overview

Prothrombin, also known as Coagulation Factor II (FII), is a vitamin K-dependent glycoprotein synthesized in the liver. It is the inactive precursor (zymogen) to thrombin (Factor IIa), a serine protease that plays a central role in the blood coagulation cascade. Upon activation by the prothrombinase complex (composed of Factor Xa, Factor Va, phospholipids, and calcium ions), prothrombin is cleaved to form thrombin. Thrombin then converts soluble fibrinogen into insoluble fibrin, which forms the structural meshwork of a blood clot, and also activates other coagulation factors and platelets. Therapeutically, prothrombin can be administered, often as a component of Prothrombin Complex Concentrates (PCCs), to replenish deficient coagulation factors and restore normal hemostasis, particularly in conditions like prothrombin deficiency or to reverse the effects of certain anticoagulants. [1, 2, 4, 5, 7, 8, 14, 15, 23]

Other names
Thrombogen
02

Targets

F2 (Thrombin)

Beyond the preview

Go deeper on Prothrombin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prothrombin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call